Bacterial InfectionsNCT05106803
Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan
An observational study of Bacterial Infections and Antibiotic Resistant Infection, run by Yarmouk University at 1 site in Jordan.
Trial summary
The main aim of the study was to identify the various pathogens associated with surgical site infections and their antibiotic susceptibility in a governmental hospital in northern Jordan. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Bacterial Infections, Antibiotic Resistant Infection, Surgical Site Infection
- What is being tested?
- ciprofloxacin
- How many people
- 24 participants
- Where
- 1 siteJordan
- Study dates
- 1 Aug 2019to 1 Oct 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Child, Adult, Older adult
Study population: A hospital-based prospective study was carried out in Public-Teaching Hospital in northern Jordan with a total capacity of 400 beds, All patients meet the criteria of getting post-operative wound infections in different surgical wards and ICUs.
Who may be able to join
- Post-Surgical Wound Infection
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Antibiotic Profile of Pathogenic Bacteria Isolated From Postsurgical Site Infections in Public Hospitals in Northern Jordan
The main aim of the study was to identify the various pathogens associated with surgical site infections and their antibiotic susceptibility in a governmental hospital in northern Jordan.
Read the detailed description
Background: Surgical site infections are hospital-acquired, vary from one hospital to another, and can cause significant postoperative morbidity, mortality, and prolonged hospital stay.
Aim: The main aim of the study was to identify the various pathogens associated with surgical site infections and their antibiotic susceptibility in a governmental hospital in northern Jordan.
Methods: Postsurgical wound samples were collected and processed in a microbiology laboratory using standard microbiological techniques. Antibiotic susceptibility tests were performed using 13 antibiotics covering the gram-positive and gram-negative bacteria using the disc diffusion test.
- Being tested
- ciprofloxacin
- Keywords
- antimicrobial, hospital, post-surgical infection, surgery
- Medical subject headings
- Bacterial Infections, Surgical Wound Infection
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ciprofloxacinDrug
Also called trimethoprim-sulfamethoxazole, norfloxacin, erythromycin, chloramphenicol
Antibiotics used in vitro n the study
| Study group | Role | What they receive |
|---|---|---|
| Wound infection | Patients with surgical site infection as diagnosed by the attending physician Receives: Drug: ciprofloxacin |
What is being measured
The primary outcome is the main question the study is designed to answer.
Positive culture
Positive swab culture from the wound
Measured: August 2019 to October 2019
Secondary outcomes (2)
Gram stain and type of Bacteria
Gram stain and type of Bacteria grown in culture media
Measured: August 2019 to October 2019
Antibiotic Susceptibility
Antibiotic Susceptibility to the isolated organisms
Measured: August 2019 to October 2019
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Nov 2021
- Study start1 Aug 2019
- Primary completion1 Oct 2019
- Study completion1 Oct 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Bacterial InfectionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 24 participants (actual)
Sponsor and investigators
- Lead sponsor
- Yarmouk University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Raed M Ennab, Yarmouk University
- Investigators
- Raed M Ennab, Principal investigator, Department of Clinical Sciences, Faculty Of Medicine, Yarmouk University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05106803
- Sponsor's protocol ID
- Antibiotic profile in Jordan
- Status last verified
- Oct 2021
- First submitted
- 24 Oct 2021
- Last updated
- 4 Nov 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Nov 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Antibiotic Profile of Pathogenic Bacteria Isolated From Postsurgical Site Infections in Public Hospitals in Northern Jordan
- ClinicalTrials.gov ID
- NCT05106803
- Acronym / sponsor ID
- Antibiotic profile in Jordan
- Keywords
- antimicrobial, hospital, post-surgical infection, surgery
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 24 participants (actual)
- Lead sponsor
- Yarmouk UniversityUniversity, hospital or other
- Study start
- 1 Aug 2019 (actual)
- Primary completion
- 1 Oct 2019 (actual)
- Study completion
- 1 Oct 2019 (actual)
- First posted
- 4 Nov 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main aim of the study was to identify the various pathogens associated with surgical site infections and their antibiotic susceptibility in a governmental hospital in northern Jordan.
Detailed description
Background: Surgical site infections are hospital-acquired, vary from one hospital to another, and can cause significant postoperative morbidity, mortality, and prolonged hospital stay.
Aim: The main aim of the study was to identify the various pathogens associated with surgical site infections and their antibiotic susceptibility in a governmental hospital in northern Jordan.
Methods: Postsurgical wound samples were collected and processed in a microbiology laboratory using standard microbiological techniques. Antibiotic susceptibility tests were performed using 13 antibiotics covering the gram-positive and gram-negative bacteria using the disc diffusion test.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Wound infection | – | Drug: ciprofloxacinPatients with surgical site infection as diagnosed by the attending physician |
Who may qualify
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- A hospital-based prospective study was carried out in Public-Teaching Hospital in northern Jordan with a total capacity of 400 beds, All patients meet the criteria of getting post-operative wound infections in different surgical wards and ICUs.
Key inclusion criteria (1 listed)
- Post-Surgical Wound Infection
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ciprofloxacinAlso: trimethoprim-sulfamethoxazole, norfloxacin, erythromycin, chloramphenicolAntibiotics used in vitro n the study | Drug | Wound infection |
Primary outcome
Positive culture
Time frame: August 2019 to October 2019
Positive swab culture from the wound
2 secondary outcomes
Gram stain and type of Bacteria
Time frame: August 2019 to October 2019
Antibiotic Susceptibility
Time frame: August 2019 to October 2019
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Nov 2021.
- Individual participant dataSharing planned: No
Related trials for Bacterial Infections
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
Active, not recruitingPhase 2
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
Pneumococcal Disease
Not yet recruiting
Early Pathophysiology of Hidradenitis Suppurativa and Prediction of the Risk of Progression: a Prospective Cohort
Hidradenitis Suppurativa (HS)
RecruitingPhase 3
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
Pneumococcal Disease
RecruitingObservational study
Modeling Host-Pathogen Interaction Using Lymphoid Organoids
Staphylococcal Infections
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Raed M Ennab principal investigator
Department of Clinical Sciences, Faculty Of Medicine, Yarmouk University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Bacterial Infections and Antibiotic Resistant Infection, run by Yarmouk University at 1 site in Jordan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Jordan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Positive culture (time frame: August 2019 to October 2019). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2021.